Work

Genetic variants in COX-2, non-steroidal anti-inflammatory drugs, and breast cancer risk: the Western New York Exposures and Breast Cancer (WEB) Study

Year: 2010

Type: article

Study design: Observational Study

Source: Breast Cancer Research and Treatment

DOI: 10.1007/s10549-010-1082-x

Authors: Theodore M. Brasky, Matthew R. Bonner, Kirsten B. Moysich, Heather M. Ochs-Balcom, Catalin Marian, Christine B. Ambrosone, Jing Nie, Meng Hua Tao, Stephen B. Edge, Maurizio Trevisan, Peter G. Shields, Jo L. Freudenheim

Institutions: Fred Hutch Cancer Center, University at Buffalo, State University of New York, Roswell Park Comprehensive Cancer Center, Georgetown University, Georgetown Lombardi Comprehensive Cancer Center, Nevada System of Higher Education

Language: English

Topic: Inflammatory mediators and NSAID effects

Subfield: Pharmacology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: U.S. Department of Defense, Breast Cancer Research Foundation, National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism, National Cancer Institute, National Center for Research Resources

Awards: Methylation and Oxidation in Breast Cancer Epidemiology, G1965854464, G2391680147, G3035093210, Established Investigator Award Anti-Inflammatory Exposures in Cancer Prevention, G499732063, G6015941648, Estrogen Receptor 1 Gene, Adiposity, and Breast Cancer

OpenAlex ID: W1973769396

FWCI: 1.436

Cites: 40

Cited by: 31

Related to: 10